Life Sciences Industry Accelerates Growth and Navigates COVID-19 with eClinical Solutions’ ASCEND Clinical Data Services

Share Article

Boston pharma tech innovator supports faster clinical trials and regulatory drug approvals with advanced technology platforms and statistical expertise

“With ASCEND Clinical Data Services, we’re answering the call from emerging and mid-market sponsored trials for increased data access and control,” said Raj Indupuri, Co-Founder and CEO, eClinical Solutions.

With COVID-19 severely disrupting clinical studies, eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services that accelerate drug development, has introduced ASCEND Clinical Data Services™ to help emerging and mid-market life sciences companies optimize their clinical data for rapid database lock and improved speed in drug submissions.

Clinical data management teams are increasingly outsourced, and sponsors are now working with an average of five data sources per trial. This has created data chaos and integration challenges, which are causing cycle time delays of 40 percent in the Last Patient Last Visit to Database Lock cycle time metric for sponsors using four or more data sources.* The COVID-19 pandemic has also been a catalyst for sponsors to move to more decentralized trial models that enable greater participation by patients from home and expanded centralized monitoring capabilities. ASCEND Clinical Data Services helps to address these challenges by combining leading clinical technology platforms, including eClinical Solutions’ elluminate® and the Medidata Rave Clinical Cloud, with clinical data management and biostatistical knowledge and expertise. This leads to more efficient data acquisition, standardization, data review, and analytics for improved decision making. Medidata is a Dassault Systèmes company.

“With ASCEND Clinical Data Services, we’re answering the call from emerging and mid-market sponsored trials for increased data access and control,” said Raj Indupuri, Co-Founder and CEO, eClinical Solutions. “Approvals for important treatments rely on data quality, and as data sources increase and clinical trials move towards virtualization, it is now critical for life sciences companies to access their data in real-time to achieve faster study cycle times and insights. Along with the ASCEND offering, our recent accreditation for Medidata RTSM reinforces our position as a true leader in providing agile, best-in-class clinical data services that are supported by cutting-edge technology platforms like elluminate and Medidata’s Clinical Cloud.”

“Since 2007, eClinical Solutions and Medidata have built a long-standing relationship driven by a shared mission of leveraging technology to improve the clinical research process,” said Katrina Rice, EVP, Professional Services, eClinical Solutions. “With seven accreditations across the Medidata Rave Clinical Cloud, eClinical Solutions and ASCEND Clinical Data Services are uniquely positioned to deliver increased value to Medidata Clinical Cloud clients through optimized study builds, data standardization and technology enabled data management and biostatistics services.”

For more on ASCEND Clinical Data Services, join our introductory webinar on Thursday, August 20: https://www.eclinicalsol.com/webinars/introduction-to-ascend-clinical-data-services/.

*The Tufts-eClinical Solutions Data Strategies & Transformation Study, 2019

About eClinical Solutions LLC
eClinical Solutions is a leading global provider of cloud-based enterprise software and software-driven clinical data services. The elluminate platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies. For more information, visit http://www.eclinicalsol.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cameron Thomas
Visit website